A hematological and inflammatory marker-based model for prostate carcinoma diagnosis

Prostate carcinoma (PC) is the most frequently diagnosed malignancy and the third leading cause of cancer-related death among men in the United States, with over 160,000 new cases reported annually. While prostate-specific antigen (PSA) screening has advanced the early detection and management of PC...

Celý popis

Podrobná bibliografia

Vydané v:	American journal of cancer research Ročník 15; číslo 6; s. 2551
Hlavní autori:	Guo, Peiyi, A, Garu, Chen, Tao, Guo, Yuanqing, Tang, Yubo, Pan, Jiangang, Wang, Bin, Gong, Rui, Chen, Guangfu, Huang, Sheng
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.01.2025
Predmet:	risk Hematology clinical significance diagnostic model prostate carcinoma
ISSN:	2156-6976, 2156-6976
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!